Events
Medical Crossfire®: ADCs and Bispecifics in Lung Cancer – Hype, Hope, or a New Standard
Room 103, Grand Ballroom, 1F
Presented by Physicians’ Education Resource. Supported by an independent educational grant from Merck & Co., Inc.
Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies
Room 105, Grand Ballroom, 1F
Presented by Peerview. Supported by an independent educational grant from BMS/BioNTech.
The Lung Cancer Landscape: Covering Key Advances in NSCLC and SCLC
Room 104, Grand Ballroom, 1F
Presented by Medscape. Supported by independent educational grants from Gilead Sciences, Inc.; Jazz Pharmaceuticals, Inc.; and Nuvalent.
From Data to Decisions in HER2-Overexpressing NSCLC
Room E5, Conference Room E, 3F
Presented by Peerview. Supported by an independent educational grant from Daiichi Sankyo, Inc.
Beyond PD-L1: Personalizing Immunotherapy in Genomic Subsets of Advanced NSCLC
Room 104, Grand Ballroom, 1F
Presented by Medscape. Supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.



